Synthetic digital twins based on medical data accelerate the acquisition, labelling and decision making procedure in digital healthcare. A core part of digital healthcare twins is model-based data synthesis, which permits the generation of realistic medical signals without requiring to cope with the modelling complexity of anatomical and biochemical phenomena producing them in reality. Unfortunately, algorithms for cardiac data synthesis have been so far scarcely studied in the literature. An important imaging modality in the cardiac examination is three-directional CINE multi-slice myocardial velocity mapping (3Dir MVM), which provides a quantitative assessment of cardiac motion in three orthogonal directions of the left ventricle. The long acquisition time and complex acquisition produce make it more urgent to produce synthetic digital twins of this imaging modality. In this study, we propose a hybrid deep learning (HDL) network, especially for synthetic 3Dir MVM data. Our algorithm is featured by a hybrid UNet and a Generative Adversarial Network with a foreground-background generation scheme. The experimental results show that from temporally down-sampled magnitude CINE images (six times), our proposed algorithm can still successfully synthesise high temporal resolution 3Dir MVM CMR data (PSNR=42.32) with precise left ventricle segmentation (DICE=0.92). These performance scores indicate that our proposed HDL algorithm can be implemented in real-world digital twins for myocardial velocity mapping data simulation. To the best of our knowledge, this work is the first one investigating digital twins of the 3Dir MVM CMR, which has shown great potential for improving the efficiency of clinical studies via synthesised cardiac data.

Download full-text PDF

Source
http://dx.doi.org/10.1109/JBHI.2022.3158897DOI Listing

Publication Analysis

Top Keywords

digital twins
20
3dir mvm
16
myocardial velocity
12
hybrid deep
8
deep learning
8
synthetic digital
8
digital healthcare
8
data synthesis
8
cardiac data
8
imaging modality
8

Similar Publications

An ODE-based swift and dynamic sewer airflow model.

Water Res

December 2024

School of Energy and Environment, City University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Marine Pollution, City University of Hong Kong, Hong Kong SAR, China. Electronic address:

Airflow models are powerful tools for ventilation design to achieve odour and corrosion mitigation in sewer networks. Currently, there lacks a model able to efficiently predict in-sewer dynamic airflows, as all available dynamic models with an acceptable accuracy are computationally demanding. In this study, a swift dynamic airflow model based on an ordinary differential equation (ODE) is derived by simplifying the one-dimensional Navier Stokes Equations (NSE), supported by the observation that the NSE solutions always display negligible spatial variations in air velocity when applied to a sewer conduit.

View Article and Find Full Text PDF

Digital twins, driven by data and mathematical modelling, have emerged as powerful tools for simulating complex biological systems. In this work, we focus on modelling the clearance on a liver-on-chip as a digital twin that closely mimics the clearance functionality of the human liver. Our approach involves the creation of a compartmental physiological model of the liver using ordinary differential equations (ODEs) to estimate pharmacokinetic (PK) parameters related to on-chip liver clearance.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Aitia, Somerville, MA, USA.

Background: Amyloid, Tau and neurodegeneration (ATN), the hallmark pathologies of Alzheimer's Disease (AD) translating to measurable biomarkers are important for disease modifying therapeutics.

Method: AD Digital-Twins were built using AITIA's patented A.I.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.

Background: Randomized placebo-controlled trials (RCTs) are the gold standard to evaluate efficacy of new drug treatments for Alzheimer's disease. For example, the United States FDA approved the brain amyloid-targeting drug lecanemab following CLARITY AD, Biogen and Eisai's Phase 3 RCT. However, recruiting enough participants for a high-powered and demographically representative trial is difficult and expensive.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

AbbVie Inc., North Chicago, IL, USA.

Background: In Alzheimer's Disease (AD) trials, clinical scales are used to assess treatment effect in patients. Minimizing statistical uncertainty of trial outcomes is an important consideration to increase statistical power. Machine learning models can leverage baseline data to create AI-generated digital twins - individualized predictions (or prognostic scores) of how each patient's clinical outcomes may change during a trial assuming they received placebo.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!